Oral fluticasone propionate in active distal ulcerative colitis.
about
Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis.Drug therapy of ulcerative colitisTreatment of eosinophilic esophagitis: is oral viscous budesonide superior to swallowed fluticasone spray?Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity.Ulcerative proctitis: a review of pharmacotherapy and management.Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.An evidence-based systematic review on medical therapies for inflammatory bowel disease.Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis.New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.Current management of inflammatory bowel disease.Refractory ulcerative colitis treatmentGut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat.Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease.Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity.
P2860
Q26798299-E7CCCE9F-D63E-48AC-9F04-6D211E776090Q34376310-0B24F023-EEB0-488B-92B2-4D0C6FBA7C67Q34403155-BD73E86B-07C7-49B0-8075-48A37EC7C0A9Q34571174-2C92EF5C-8767-4D9F-B62C-5DB8BD8AB73EQ36659176-89CCD345-6CBE-47E4-9F2A-25C18D5D9C98Q37111844-45A37CE3-6E76-4D4A-8B40-ACB5E1855D07Q37853356-F0FD99D9-20C5-4EE7-8F03-210D42F0A483Q37862584-0F553C08-0BA3-44FC-B6DA-23F95C40DCDDQ38196945-FD19D4A2-0793-4508-884A-F587E5560677Q38625992-F1912456-4CC4-4882-8339-DE41F794312AQ38960072-4695827D-5B5D-45BE-8499-9575855D8E5EQ40046590-46E88A49-6E4F-4ACE-9F47-D6AA02FA40B1Q40708437-BA033D0B-8B01-4D29-8AC5-6CCB66150384Q42106968-98FF52C7-3A91-4671-AA7C-1D90A7539F96Q43817676-D676199E-7E78-48F7-A106-30CC46B8ABEAQ46859854-CCB98697-C828-4166-974A-B8FE4A1C201CQ47958039-1D06718F-42DC-4A7E-B541-01E37C47053BQ49957833-1B82BFC6-E01B-4724-A997-B88A7C9CFF04
P2860
Oral fluticasone propionate in active distal ulcerative colitis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Oral fluticasone propionate in active distal ulcerative colitis.
@ast
Oral fluticasone propionate in active distal ulcerative colitis.
@en
Oral fluticasone propionate in active distal ulcerative colitis.
@nl
type
label
Oral fluticasone propionate in active distal ulcerative colitis.
@ast
Oral fluticasone propionate in active distal ulcerative colitis.
@en
Oral fluticasone propionate in active distal ulcerative colitis.
@nl
prefLabel
Oral fluticasone propionate in active distal ulcerative colitis.
@ast
Oral fluticasone propionate in active distal ulcerative colitis.
@en
Oral fluticasone propionate in active distal ulcerative colitis.
@nl
P2093
P2860
P356
P1433
P1476
Oral fluticasone propionate in active distal ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1136/GUT.33.5.711
P407
P577
1992-05-01T00:00:00Z